Note: Check with your organization’s library for availability.
A. “Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia,” by Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G. Beach, Geidy E. Serrano, Xiyun Chai, Nicholas K. Proctor, Udo Eichenlaub, Henrik Zetterberg, Kaj Blennow, Eric M. Reiman, Erik Stomrud, Jeffrey L. Dage & Oskar Hansson (Vol. 26, No. 3, March 2020, p. 379-386).
www.nature.com/articles/s41591-020-0755-1
B. “Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration,” by Elisabeth H. Thijssen, Renaud La Joie, Amy Wolf, Amelia Strom, Ping Wang, Leonardo Iaccarino, Viktoriya Bourakova, Yann Cobigo, Hilary Heuer, Salvatore Spina, Lawren VandeVrede, Xiyun Chai, Nicholas K. Proctor, David C. Airey, Sergey Shcherbinin, Cynthia Duggan Evans, John R. Sims, Henrik Zetterberg, Kaj Blennow, Anna M. Karydas, Charlotte E. Teunissen, Joel H. Kramer, Lea T. Grinberg, William W. Seeley, Howie Rosen, Bradley F. Boeve, Bruce L. Miller, Gil D. Rabinovici, Jeffrey L. Dage, Julio C. Rojas, Adam L. Boxer, Leah Forsberg, David S. Knopman, Neill Graff-Radford, Murray Grossman, Edward H. Huey, Chiadi Onyike, Daniel Kaufer, Erik Roberson, Nupur Ghoshal, Sandra Weintraub, Brian Appleby, Irene Litvan, Diana Kerwin, Mario Mendez, Yvette Bordelon, Giovanni Coppola, Eliana Marisa Ramos, M. Carmela Tartaglia, Ging-Yuek Hsiung, Ian MacKenzie, Kimiko Domoto-Reilly, Tatiana Foroud & Bradford C. Dickerson (Vol. 26, No. 3, March 2020, p. 387-397).
www.nature.com/articles/s41591-020-0762-2
C. “A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease,” by Nicolas R. Barthélemy, Yan Li, Nelly Joseph-Mathurin, et. al. (Vol. 26, No. 3, March 2020, p. 398-407).
